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Abstract
Adherence to medical regimes and the difficulties associated with
patient adherence are well documented. Furthermore, non-adherence
with prescribed medication is ubiquitous. Regarding HIV, strict
adherence to combination highly active antiretroviral therapy regimes
is a prerequisite for immunological reconstitution. Certain factors have
been identified as predicting non-adherence. However, the role of
personality variables on adherence has been neglected, specifically
with regards to personality pathology. Moreover, there is a high rate of
comorbidity between HIV and Axis II disorders, including BPD. Despite
controversy, the DSM-IV-TR identifies nine fundamental criteria
required for the diagnosis of BPD to be made. These criteria are
considered separately in an attempt to elucidate their potential role on
non-adherence. Clinically, it is likely that the criteria interact to create
a gestalt effect, further complicating adherence.
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Abstrak
Patient voldoening ter mediese aanbevele en die probleme geassosier
daarmee is goed gedokumenteer. En verder is dit allerdags dat
patlente nie met hul voorgeskrewe medikasie voldoen nie. In verband
met MIV, streng voldoening tot HAART is a voorvereiste vir
immunologiese hersamestelling. Sekere faktore is geidentifiseer wat
voldoening en die teenoorgestelde daarvan voorspel. Alhoewel, die rei
van persoonlikheid veranderlikes op voldoening is nie in ag geneem
nie, spesifiek in verband met persoonlikheid patologie. Bowenal, is
daar n hoe frekwensie van komorbiditeit tussen MIV en As II steurings,
insluitend BPO. Ten spyte van kontroversie, die OSM-IV-TR identifiseer
nege fundementele kriteria, waarvan vyf teenwoordig moet wees vir n
diagnose van BPO. Hierdie kriteria word individueel bespreek in n
poging om hulle impak op patiente voldoening te illustreer. Klinies is
dit heel moontlik dat daar interaksie is tussen die kriteria wat n gestalt
effek sal skep, wat voldoening weer verder sal kompliseer.
IV
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1.1. Introduction
This paper is divided into three sections. The first discusses the
concept of patient adherence to medical prescriptions, and
highlights the suboptimal rate of adherence documented in the
literature. This is of particular concern to the treatment of the
human immunodeficiency virus (HIV) given the consequences of
poor adherence. The role of personality and its influence on patient
adherence as well as the lack of research into this field is also
discussed.
The second section provides a brief overview of personality
disorders, with specific reference to borderline personality disorder
(BPD). Included in this section are the exigencies associated with
the disorder as well as the epidemiology and treatment of BPD.
The third sections attempts to integrate the previous two
sections by illustrating the potential means by which BPD may
negatively influence a patient's adherence to the treatment of HIV.
1.2. Adherence
The concept of patient adherence to medical regimes prescribed
for a variety of clinical syndromes such as hypertension, epilepsy,
asthma, and other chronic illnesses is well documented (Johnston
Roberts & Mann, 2000). Willey, Redding, Stafford, Garfield, Geletko,
Flanigan, Melbourne, Mitty, and Caro (2000) state that non
adherence on the other hand can either be intentional or
unintentional. In addition to this variable, Ware, Wyatt, and
Tugenberg (2005) state that multiple confounding difficulties
associated with patient adherence have been illustrated.
Consequently, as a result of the associated difficulties, non-
adherence with prescribed medication or ignoring medical advice is
ubiquitous (Karasz, Dyche, & Selwyn, 2003; Wright, 2000; Walsh,
Horne, Dalton, Burgess, & Gazzard, 2001), with some authors
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stating that patient adherence is the most powerful variable
hindering the success of applied medicine (Dunbar & Stunkard,
1979, cited in Ekstrand & Chesney, 2002).
There is consensus in the literature that of the medical conditions
already studied, none are as complex to manage as the human
immunodeficiency virus (HIV)(Walsh, Horne, Dalton, Burgess, &
Gazzard, 2001; Ekstrand & Chesney, 2002). Consequently, it could
be expected that adherence to treatment of HIV would be
proportionately onerous and complex. The treatment of HIV is
complicated (Joly & Yeni, 2000) given, amongst others its broad
individual variance with which it presents clinically and its
unpredictable course; the rapid developments in treatment
protocols; and the stigma and discrimination associated with the
disease (Remien & Rabkin, 2002). However, the use of combination
highly active antiretroviral therapy (HAART) has significantly
improved the medical treatment of HIV (Karasz, Dyche, & Selwyn,
2003) and dramatically changed the course of clinical management
in HIV-positive (HIV+) patients in the last five years (Spire, Duran,
Souville, Leport, Raffi, & Moatti, 2002; Ricart, Cohen, Alfonso,
Hoffman, Quinones, Cohen, & Indyk, 2002).
1.3. HAART
The primary function of HAART is to aggressively manage the
infection and disease through slowing down immunologic failure by
containing and suppressing replication of the virus (Hal man, Bialer,
Worth, & Rourke, 2002). The use of HAART to treat HIV has
increased to the extent that it has become established as the first
line of treatment, demonstrating superior efficacy over other
treatment options (Gulick, Mellors, & Havlir, 1998, cited in Halman,
Bialer, Worth, & Rourke, 2002). Similarly, it has proven to be
significantly effective in reducing both associated morbidity and
2
Stellenbosch University http://scholar.sun.ac.za
mortality (Mugavero & Hicks, 2004; Tang & Pillay, 2004; del Rio,
2005).
Epidemiologically, Meel (2005) reports that South Africa has the
largest HIV+ population in the world. Given this epidemic status
(Eley, In Press), the effective use of HAART becomes of pivotal
importance to public health. In light of the significant social impact
of HIV, the government is directly implicated in taking responsibility
for distributing HAART. Opie (2005) states that in South Africa this
is indeed the case, and that access to HAART is primarily via the
public health system
1.4. HAART and adherence
For HAART to be clinically therapeutic in ensuring viral
suppression, strict adherence to the medication regimes is essential
(Chesney, Morin, & Sherr, 2000; Albus, Schrneljser, Salzberger, &
Fatkenuer, 2005; Vieira, Rebocho, Sousa, & Azevedo, 2003; Belzer,
Fuchs, Luftman, Tucker, 1999). Not only does this mean doggedly
taking the pills correctly, but it may also have dietary implications
to promote absorption of the medication in the gastro-intestinal
tract as well as other health-related behavioural implications
(Halman, Bialer, Worth, Rourke, 2002).
While partial adherence with other illnesses may be acceptable,
this is not the case with HAART (Safren, Otto, Worth, Salomon,
Johnson, Mayer, Boswell, 2001). If HAART is used in a sub-optimal,
erratic, capricious manner, then mutant, treatment-resistant strains
of the virus can develop (Karasz, Dyche, & Selwyn, 2003). This will
drastically impinge on future treatment options for the host.
Furthermore it complicates the course of the HIV through the loss of
viral suppression and increase in viral replication (Halman, Bialer,
Worth, Rourke, 2002). Additionally, the resistant strain also has the
potential to be transmitted to others (Tang & Pillay, 2004). Thus,
HAART is rendered a redundant treatment option for them too
3
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(Ickovicks & Meade, 2002). In other words, adherence to HAART is
crucial for the durable reconstitution of the immune system by
maintaining therapeutic blood levels of HAART to maintain viral
suppression. Non-adherence, even for very brief episodes of time, is
thus directly proportional to increased risk for treatment failure
(Walsh, Horne, Dalton, Burgess, & Gazzard, 2001). As such, the
World Health Organization (2003, p.l0l) states that adherence to
HAART is "arguably the most important issue in successfully
managing HIV ...".
Despite the agreed upon finding that adherence is of fundamental
importance, Ickovicks and Meade (2003) as well as Eckstrand and
Chesney (2002), assert that non-adherence is common. This is
supported by research conducted by Roca, G6mez, & Arnedo
(2000). As such, the literature examining this concept is vast
(Reynolds, 2003). Studies have identified the following as
significant predictors of non-adherence
• deleterious side-effects of the medication, such
as nausea, asthenia, headache and
lipodystrophy (Halman, Bialer, Worth, Rourke,
2002)
• the unprecedented complex and demanding
nature of medication regimens (Remien &
Rabkin, 2002)
Additionally, a number of demographic variables have been
reported as being either significant predictors or a criterion on
which sub-groups can be significantly differentiated with regards to
non-adherence. Johnson et. al. (2005) identified ethnicity, age and
gender, while Ekstrand and Chesney (2002) reported socio-
economic status as being significant predictors of non-adherence.
4
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1.5. Personality and adherence
Despite the valuable contribution of the findings from studies on
adherence, the role of psychological variables on the
phenomenology of medical illness and specifically adherence has
not been taken into account adequately (Ursano, Epstein, & Lazar,
2002). Sherr (2000) concurs that the elucidation of psychological
variables, including personality, would be beneficial in developing a
comprehensive conceptualisation of adherence. Unfortunately, the
study of personality pathology is still in its infancy compared to
research into other Axis I disorders (Hyman, 2002). This finding is
reinforced by Yates (2002) who states that the mechanisms through
which personality pathology affects adherence is not clearly
understood at present due to the limited number of studies that
have been conducted in this field.
Ball and Schottenfield (1997) have demonstrated a positive
correlation between personality traits, such as neuroticism and
impulsiveness (both associated with personality pathology) and
compromised health habits. Similarly, increased levels of social
distress and Axis I disorders, including depression and anxiety, and
poorer overall functioning have been associated with the same
personality traits (Johnson, Wiliams, Rabkin, Goetz, & Remien,
1995). Additionally, Stoudemire and Thompson (1983, cited in
Ursano, Epstein, & Lazar, 2002) found that patients with BPD, an
Axis II disorder, had tremendous difficulty adhering to medical
regimens.
Penedo, Gonzalez, Dahn, Antoni, Malow, Costa, and
Schneiderman (2003) have contributed to the extant literature by
attempting to elucidate and document the relationship between
personality traits and quality of life (as measured by a sense of
purpose) and its effects on adherence in HIV+ individuals. The
conclusion of this study was that personality significantly affected
patients' quality of life, which in turn significantly influenced patient
5
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adherence to HAART. However, the focus was on intact personality
functioning, and an Axis II diagnosis was used as an exclusion
criterion for patient participation. The assumption was made that
patients with healthy personality traits, such as high extraversion
and agreeableness, had greater potential for developing a sense of
purpose or increased quality of life, which in turn would facilitate
adherence. Conversely, a compromised personality (in other words
a patient with a personality disorder) could lead to compromised
quality of life, which in turn might lead to compromised adherence.
Given the high incidence of HIV+ patients who have personality
disorders (Golding & Perkins, 1996; Johnson, Wiliams, Rabkin,
Goetz, & Remien, 1995; Ursano, Epstein, & Lazar, 2002; Angelino &
Treisman, 2001) and the paucity of research with the explicit focus
on personality variables, it becomes pivotal to examine the impact
of personality pathology (direct or mediated) on adherence. This is
supported by the researchers of the study cited above who
concluded that more circumscribed research needs to be conducted
to ascertain possible direct relationships between gross
psychopathology such as "DSM- IV criteria for borderline or
antisocial personality disorder" and HAART adherence (Penedo,
Gonzalez, Dahn, Antoni, Malow, Costa, & Schneiderman, 2003).
Paradoxically, Wright (2000) states though that neither
personality characteristics nor pathological behaviour can
adequately account for non-adherence to medical regimens, but
rather that the phenomenological meaning that the patient ascribes
to the medical intervention may have a more potent effect on the
patient's adherence. The patient with a BPD seems to be at
increased risk for failing to develop a stable and enduring sense of
meaning as a direct result of their personality pathology, which in
turn compromises their ability to experience a higher quality of life.
Consequently, their ability to adhere to medical regimens will be
compromised.
6
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2. 1. Personality Disorders
The term personality has proven to be relatively arduous and
elusive construct to conceptualise (Pervin & John, 1997 , Casey,
2000). The result being that multiple theories have been developed
to describe and account for the dynamics contained therein,
specifically relating to the structure of personality and the way
individuals resemble and deviate from each other (Westen, 1996).
Sadock and Sadock (2003) define personality as a term
describing an individual's objective behaviour and subjective inner
experience of that behaviour. Personality Disorders then, as defined
by the DSM-IV-TR (2004), are characterized by chronic maladaptive
patterns of relating to the world that are pervasive and inflexible,
and that lead to distress or impairment. Casey (2000) states that
the epidemiology of personality disorders is acutely dependent on
the population being sampled and the diagnostic instruments and
criteria utilized.
Clinically, patients with personality disorders often deny their
symptoms as they are experienced ego-syntonically (Kluger & Song,
2003; Sadock & Sadock, 2003). These patients tend to demonstrate
poor levels of insight into their condition (Nair & Lay, 2001;
Loranger, 1999) as well as poor adherence and non-compliance to
treatment regimens (Angelino & Treisman, 2001; Stilley, Dew,
Pilkonis, Bender, McNulty, Christensen, McCurry, & Kormos, 2005;
Davidson & Tyrer, 2000), which will have obvious negative
implications for treatment outcomes.
An exacerbating factor is that personality disorders often occur
co-morbidly with Axis I disorders, which subsequently complicates
the treatment course (Kaliski, 2001). Puri, Laking and Treasaden
(2002) further assert that comorbidity results in pathoplasticity, the
confounding of a clinical picture due to comorbid clinical pictures. As
such, the literature has emphasized the difficulties associated with
the treatment of personality disorders (Perry & Bond, 2000) and
7
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numerous studies have been conducted demonstrating a poorer
outcome for patients who have a comorbid Axis I and Axis II
disorder compared to those without an Axis II diagnosis (Ozkan &
Altindag, 2005; Skodol, Gunderson, Pfohl, Widiger, Livesley, &
Siever, 2002). In other words, the presence of an Axis II disorder
has been identified as a potential predictor of poor treatment
outcome of comorbid Axis I disorders.
Conversely, there is a limited amount of literature that reports
that treatment response is unaffected by the comorbid presence of
a personality disorder, with the exception of Cluster B personality
disorders. The authors state that this is consistent with other
literature on borderline personality disorder specifically (Mulder,
Joyce, & Luty, 2003). According to Ketterer, Mahr, and Goldberg
(2000), it is also well known that psychological variables such as
personality style may influence Axis III treatment.
2.2. Borderline Personality Disorder
Traditionally, BPD has been understood in psychodynamic terms
stemming from Kernberg's (1967) formulations as well as other
psychoanalytic object relations theories such as Mahler (Hamilton,
1990). Unfortunately, the literature on BPD has become
characterized by pejorative language (Wirth-Cauchon, 2001) with
the overarching idea that it is an untreatable disorder (Arntz, 2005).
However, contemporary research has challenged this notion, such
as Linehan, Armstrong, Suarez, Allmon, and Heard (1991) and
other cognitive-behavioural approaches, with a shift away from
psychodynamic conceptualizations to an emphasis on affective
regulation and impulse control (Homan, 2002).
The current diagnostic status of BPD is ambiguous (Benazzi,
2005) and the term BPD has developed into a contentious
nosological issue, receiving mounting interest from mental health
professions (Skodol et ai, 2002; Mohan 2002). By and large this
8
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attention seems due to the unrelenting complexities associated with
the dynamic etiology (Rosenthal, Cheavens, Lejuez, & Lynch,
2004), as well as the diagnosis and treatment of the disorder
(Sperry, 1995). The Harvard Mental Health Letter (2002) states that
BPD can present as one of the most convoluted and complicated
personality disorders. Despite the interest and what has been
researched already, Hyman (2002) states that more meaningful
research into the disorder is still needed to expound it further given
the heterogeneity with which it presents. Arntz (2005) on the other
hand, states that despite the tremendous amount of research being
conducted on BPD, little is known from empirical research on the
disorder.
Clinically, BPD is a serious disorder (Lieb, Zanarini, Schmahl,
Linehan, & Bohus, 2004). It is characterized by marked instability
and chaos (Barlow & Durand, 1999), which manifests in a number
of areas: namely in (1) relationships, which are often described as
being turbulent; (2) a distorted self-image; (3) affective instability;
(4) behavioural impulsivity; and (5) sexual promiscuity (Skodol et
ai, 2002, cited in Houston, Ceballos, Hesselbrock, & Q'Bauer, 2005).
Bateman and Fonagy (2004) also assert that both clinicians and
theorists have consistently identified attachment difficulties as a
core phenomenological feature of patients with BPD.
The DSM-IV-TR (2000, p.706) criteria for making a diagnosis of
BPD are two-fold. Firstly, the symptoms identified must meet the
diagnostic criteria whereby a "pervasive pattern of instability of
interpersonal relationships, self-image, and affects; and secondly,
marked impulsivity beginning by early adulthood and present in a
variety of contexts must be exhibited in addition to at least five of
the following:
• Frantic efforts to avoid real or imagined
abandonment
9
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• A pattern of unstable and intense interpersonal
relationships characterized by alternating between
extremes of idealization and devaluation
• Identity disturbance: strikingly and persistently
unstable self-image or sense of self
• Impulsivity in at least two areas that are potentially
self-damaging (e.g. spending, sex, substance abuse,
reckless driving, binge eating)
• Recurrent suicidal behaviour, gestures, or threats, or
self-mutilating behaviour
• Affective instability due to marked reactivity of mood
(e.g. intense episodic dysphoria, irritability, or
anxiety usually lasting a few hours and only rarely
more than a few days)
• Chronic feelings of emptiness
• Inappropriate, intense anger or difficulty controlling
anger (e.g. frequent displays of temper, constant,
recurrent physical fights)
• Transient, stress-related paranoid ideation or severe
dissociative symptoms
These criteria are often interpreted very differently by clinicians.
As mentioned before, this becomes a site for contention. For
example, Bateman and Fonagy (2004) state that the OSM-IV
criteria omits to take into account several salient cognitive factors,
such as schemata that are specific to patients with BPO. Others,
such as Layden, Newman, Freeman, and Morse (1993) posit that
the following heuristic markers are generally reliable in diagnosing
the disorder:
• The patient states, "I've always been this way. This
is who I am."
10
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• The patient demonstrates chronic noncompliance
with the therapeutic regimen
• Therapeutic progress seems to come to a sudden halt
• The patient is unaware of the negative effects of his
or her behaviours
• The patient misses many sessions, arrives late, and
sometimes leaves abruptly
• The patient exhibits an extreme all-or-nothing style
of thinking
• the patient frequently does things that cause some
sort of self harm
The implicit assumption in this list developed by Freeman and
Morse (1993) is that a distinction can be made between BPD and
other diagnoses based on this list. However, it is questionable
whether this is valid. The emphasis here should be on the term
"heuristic" which suggests a subjective, phenomenological
experience, and is not empirically based. Additionally, developing
heuristic markers is problematic given that only five of nine criteria
need to be fulfilled to make a diagnosis. Statistically, this equates to
151 possible combinations of the disorder to develop -it is possible
for two patients to be diagnosed as having BPD and yet only share
one of the nine criteria (Bateman & Fonagy, 2004). Thus heuristic
markers are likely to be unreliable in facilitating reliable diagnosis.
Freeman and Fusco (2004) also attempt to identify common
reliable clinical presentations of patients with BPD. They state that
patients with BPD often present with chronic problems that have
affected a significant part of their lives in a variety of different
contexts. The authors attribute this to characteristic personality
traits specific to BPD, namely:
11
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• A crisis-prone style, with their baseline functioning
often remaining in a state of being overwhelmed
• Heightened sensitivity, often resulting in a cascade of
negative outcomes
• Dichotomous thinking
The result of these traits interacting with each other is that the
patient often has poor coping and problem solving skills, and has a
tendency to inflate minor stressors into catastrophic events, thus
further exacerbating their already stressful experience of life. Some
authors purport that the instability of a patient with BPD manifests
on a substrate of emotional dysfunctioning and
hyperresponsiveness (Herpertz, 2003), characterized by a range of
acute dysphoric affect (Lieb, Zanarini, Schmahl, Linehan, & Bohus,
2004).
Additionally, they form intense, but fragile attachments with
others, which are not necessarily reciprocated, and fear the loss of
these attachments. Similarly they violate relationship boundaries,
but are haunted by feelings of chronic emptiness (Sadock & Sadock,
2003). In an effort to cope with these feelings, they may channel
their emotions either outward in aggressive acts, or inward in self-
mutilating ways (Comer, 2001).
2.2. Epidemiology
Whilst about 10% to 20% of the general population may fulfill the
criteria for one or more personality disorders (Kluger & Song, 2003;
Nair & Lay, 2001) there is some variability of figures quoted for
individuals who meet the criteria for a diagnosis of BPD. Torgersen
et al. (2001, cited in Lieb, Zanarini, Schmahl, Linehan, & Bohus,
2004) states that the weighted prevalence of BPD in adult
populations varies between 0.7% in Norway to 1.8% in the USA.
Comer (2001) reports figures of 20/0, with Arntz (2005) concurring,
12
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citing an average of 2% in the general adult population. Sadock and
Sadock (2003) tend to agree with these figures, stating that no
definitive epidemiological research is available, but that estimates
tend to cluster around 1% to 2% of the population.
Allwood and Nair (2001) report that women are disproportionately
susceptible to mental health problems, and there is consensus in
other literature that BPD too is generally more commonly diagnosed
in women than in men (Puri, Laking, & Treasaden, 2002; Kluger &
Song, 2003; Nair & Lay, 2001; Sadock & Sadock, 2003). Within
psychiatric populations, BPD tends to account for a significant
proportion of the population, with figures cited ranging from
between 10% to 20% (Guttman, 2002; Barlow & Durand, 1999).
2.3. Treatment
Zanarini, Frankenburg, Khera, and Bleichman (2001) state that
most patients with BPD present for treatment in late adolescence,
and characteristically, become high service users of psychological
resources. Compared to patients with other personality disorders,
BPD is associated with the highest utilization of mental health
resources (Bender, 2001).
Lieb et al. (2004) report that patients with BPD present for
treatment at varying degrees of severity, with the most severe
being those with behavioural dyscontrol. Together with the other
features of BPD, such as acute dysphoria, a lethal cocktail is created
placing the patient at compounded risk toward suicidal ideation and
attempts. Naturally, the target of an intervention with such a
patient is to reduce suicidal behaviour.
BPD patients have a number of psychological treatment options.
Individual psychotherapy, which has traditionally been the
treatment of choice for BPD (Gunderson, 2000) as well as group
therapy (Stone, 2000, cited in Comer, 2001) may lead to varying
degrees of improvement (Links & Heslegrave, 2000). Bateman and
13
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Fonagy (2000) report though that valid research instruments
measuring quantifiable personality change attributable to
psychotherapy need to be designed to measure these constructs.
Currently there is a change in focus for treatment of BPD though,
with the emphasis being on time-bound psychotherapy and targeted
pharmacotherapy (Mohan, 2001), although other forms of
psychotherapy are still indicated depending on the idiopathic needs
of the patient (Harvard Mental Health Letter, 2002). One such form
of manualised therapy is Dialectical-Behavioural Therapy (DBT)
(Davidson & Tyrer, 2000). Developed by Linehan (1987), and
supported by her groundbreaking research demonstrating DBT's
efficacy over other interventions (Arntz, 2005), DBT is a behavioural
conceptualization which proposes that dysfunction is a product of
emotional dysregulation (Freeman & Fusco, 2004). The primary
focus of DBT therefore is to facilitate and bolster emotional
regulation skills (Linehan, 1987). Initially, it was developed as a
goal-oriented, comprehensive, out-patient programme, but in-
patient programmes have subsequently also been developed (Bohus
et ai, 2004). Whilst DBT has established itself as a useful
intervention, empirical evidence lending itself toward an emotional
regulation pathogenesis of BPD is somewhat limited (Arntz, 2004).
Pharmacotherapy is also sometimes indicated in treating BPD
individuals, especially if it is used adjunctively to allow BPD patients
to be more amenable to psychotherapy (Bateman & Fonagy, 2004).
Tyrer (2000) states that pharmacotherapy is used more frequently
to treat BPD than any of the other personality disorders. Of the
psychotropic medications available, Mohan (2002) states that
neuroleptics have been the most widely researched in treating BPD,
which have demonstrated efficacy in treating transient psychotic
symptoms and emotional regulation.
The treatment of BPD patients has come to be regarded as being
notoriously difficult (Nair & Lay, 2001) and complicated for the
14
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psychotherapist (Arntz, 2005). Of all the psychiatric conditions and
personality disorders, no other seems as distinguishable with
regards to the complexities associated with treatment, with many
practitioners refusing or being skeptical to work with BPD patients
(Barlow & Durand, 1999; Tse, 2001). These patients
characteristically do not complete their treatment programmes,
whether it be in psychotherapy or psychopharmacotherapy, often
creating set-backs in treatment just as progress is being realized.
The DSM- IV- TR (2000) states that patients with BPD are prone to
developing patterns of behaviour whereby they undermine
themselves as a goal is about to be fulfilled.
Renneberg, Heyn, Gebhard, and Bachmann (2005) state that
patients with BPD have tremendous difficulty with their personal
and social relationships. Kluger and Song (2003) report similar
dynamics between patients with BPD and their mental health
practitioners and other service providers, which often become
turbulent and strained, thereby demonstrating their global tendency
to form intensely disorganized attachments (Bateman & Fonagy,
2004). Patients with BPD, according to Ohshima (2001) are more
demanding, manipulative, and have poor conflicted relationships
with medical personnel than non-BPD patients. This intense inter-
personal dynamic is likely to impact significantly on the treatment
regimens of BPD.
As stated previously, BPD patients are high-users of mental
health facilities, and as such present frequently for treatment, but
often characteristically miss psychotherapy sessions or arrive late
(Layden, 1993). Consequently, their behaviour is interpreted as a
paradoxical attempt to sabotage their therapeutic trajectory. The
tendency of the BPD patient to use primitive defence mechanisms of
splitting and projective identification (Puri, Laking, & Treasaden,
2002) results in their relationships being all-good or all-bad. This
property of their interpersonal relationships includes their
15
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relationships with their psychologist, psychiatrist or other health-
care practitioners, making it exceedingly difficult to form a durable
working collaborative alliance with the patient.
Gunderson (2000) reports that research conducted into the
alliance formed between BPO patients and their psychotherapist,
has demonstrated generally higher scores for degree of alliance at
the outset of therapy, but that research has yielded mixed results
as to how stable the alliance remained longitudinally. Additionally,
given the BPO patient's tendency to oscillate between idealization
and devaluing (Guttman, 2002), medical and health
recommendations made by professionals are either likely to be
revered or ignored by the patient. Consequently, a vacillating
pendulum-like dynamic ranging from adherence to ignorance could
be set in motion.
As such, the proposed theoretical study will attempt to address
the need for identifying pathways between personality pathology
and non-adherence to HAART, by providing a theoretical exposition
of the potential link between the stipulated criteria for a diagnosis of
BPO to be made, as determined by the OSM-IV-TR (2000) and the
potential ways these characteristics may affect adherence.
3. Borderline Personality Disorder and adherence
This section of the thesis aims to integrate the literature on
treatment adherence to HAART and the potential impacts on
adherence implicated in each of the diagnostic criteria of BPO as
stipulated by the OSM-IV-TR (2000). The section is organized so
that it follows the list of criteria required for the diagnosis of BPO.
The OSM-IV-TR (2000, p.706) criteria for making a diagnosis of
BPO are two-fold. Firstly, the symptoms identified must meet the
diagnostic criteria whereby a "pervasive pattern of instability of
interpersonal relationships, self-image, and affects; and secondly,
marked impulsivity beginning by early adulthood and present in a
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variety of contexts must be exhibited in addition to at least five of
the following:
3.1. Criterion 1
The first criterion is evidence of frantic efforts to avoid real or
imagined abandonment. Clinically, this can lead to profound
changes in self-image, affect, cognition and behaviour when
pending separation, rejection, or loss of external structure is
perceived.
The patient with BPD may be exquisitely sensitive to rejection or
perceived loss of the medical physician or any other person whom
the patient has an attachment to. Consequently, if the attachment
figure were perceived or experienced as being lost, the patient
would be expected to have a number of significant psychological
changes associated with the loss. This loss of the physician is likely
to be experienced often in the South African public health care
system where patients are treated by students and interns who
rotate at regular intervals within the health system. Given that
HAART is primarily dispensed at public institutions (Opie, 2005),
patients with BPD will be confronted with this dynamic regularly.
The changes associated with loss may influence the patient's
ability to adhere to HAART in that the patient, in the context of the
loss, functions in a state of psychological disequilibrium that
impedes their ability to function effectively and functionally.
Adherence to HAART is likely to become of peripheral importance to
the patient, with the primary goal being to avoid the abandonment.
The patient with BPD may also reject the HAART as a symbolic
representation of the abandoning clinician, or the patient may
project their feelings of rejection onto the HAART because it is
associated with the clinician. Adherence would likely remain of
secondary or even tertiary importance until the relationship with the
attachment figure is restored, which is likely to be problematic in
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the public health system. Not only HAART adherence, but a large
number of areas of functioning will likely be influenced by this
dynamic.
3.2. Criterion 2
The second criterion is a pattern of unstable and intense
interpersonal relationships characterized by alternating between
extremes of idealization and devaluation. Patients with BPD may
idealize caregivers and demand to spend a considerable amount of
time with them. Additionally they may offer empathy to caregivers,
on condition that it is reciprocated.
The patient with BPD may form an intense, but unstable
bifurcated relationship with, amongst others, their medical
physicians. Similarly, they are prone to acutely dramatic shifts in
their views regarding others, and will vacillate between idealization
and devaluing of them. When idealizing, the patient is likely to
adhere to their medication, whereas when devaluing, the patient is
likely to ignore medical advice or minimize the importance of
adhering as per instruction. They may justify their behaviour by
projecting hostile feelings toward the self onto the physician, which
will facilitate a dismissive attitude towards the physician's
prescriptions. A pattern of unstable and unpredictable adherence
could be set in motion as a function of their turbulent relationships
with both their treating physicians and other attachment figures.
3.3. Criterion 3
The third criterion is possible identity disturbance evidenced by
strikingly and persistently unstable self-image or sense of self.
There is evidence of acute and marked changes in self-image
manifesting in superficial goals and values.
This could influence the patient with BPD in terms of their
motivation to treat the HIV. Due to the instability regarding their
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sense of self, they may not be able to develop coherent goals for
their life that they are committed to. Thus, adherence to HAART
could be of compromised concern to them due to the lack of
direction as opposed to those patients who have a stable sense of
self. It has also been documented that patients with BPD often
underestimate their abilities as a goal is being realized, which
impedes the attainment of that goal. This may be a function of an
unstable self-image. In terms of adherence, the patient may thus
initially adhere to their HAART, but when physiological goals are
within reach as measured by indices such as CD4 counts and viral
loading, the patient may not follow prescriptions, with adherence
being compromised.
3.4. Criterion 4
The fourth criterion is impulsivity in at least two areas that are
potentially self-damaging. For example, the person with BPD may
impulsively and irresponsibly spend large amounts of money; be
sexually promiscuous and take part in unsafe sex practices; abuse
substances; drive recklessly or binge eat.
HAART requires strict long-term, chronic adherence (Chesney,
Morin, & Sherr, 2000; Albus, schrnelser, Salzberger, & Fatkenuer.
2005; Vieira, Rebocho, Sousa, & Azevedo, 2003; Belzer, Fuchs,
Luftman, Tucker, 1999). The patient with BPD may experience
tremendous difficulty in maintaining this stability given their
vulnerability to poor impulse-control. Consequently, sporadic
intervals of impulsivity will affect adherence. In other words, the
patient may delay taking their medication accurately in favour of
another impulsive behaviour. Additionally, given the complex and
demanding nature of HAART regimens, adherence requires planning
and the ability to inhibit myopic impulses that affect the execution
of that plan in order to adhere correctly. For example, a patient with
BPD who abuses substances impulsively directly compromises their
19
Stellenbosch University http://scholar.sun.ac.za
ability to adhere to HAART, given the constitutional effects of
substances on one's behaviour and cognition. As such, the BPD
patient may compromise adherence for the gratification of another
more dominant, impulsive behaviour. Another possibility is that the
patient not taking their HAART might be an impulsive behaviour in
and of itself without other more dominant impulses being present.
Similarly, the values of patients with BPD are prone to dramatic
shifts. The importance they place on physical health and immune
reconstitution may fluctuate from being of utmost importance to
being of little or no significance to them. Thus they may focus all
their energies on taking the medication correctly on the one hand,
to being indifferent and nonchalant regarding adherence on the
other. The result of this dynamic is that the medication is not taken
as prescribed, but rather is taken when it is important or of value to
the patient.
3.5. Criterion 5
The fifth criterion is recurrent suicidal behaviour, gestures, or
threats, or self-mutilating behaviour. This behaviour is often
precipitated by an expectation of increased autonomy or threat of
rejection. Self-mutilation, such as burning or cutting, in patients
with BPD is common. Clinically patients often present for help in the
context of recurrent suicidal ideation.
The patient with BPD may not adhere to HAART as a
manifestation of a suicidal threat. In other words, if the patient is
aware of the immunological sequelae following poor adherence,
they may become noncompliant as a suicidal gesture.
Consequently, a precarious pattern could develop whereby the
patient either stops taking their medication or does not take it
correctly every time they feel suicidal. Their motivation could either
be to develop a treatment-resistant virus as a means of indirectly
committing suicide, or given the urgency of their suicidal ideation
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they may not have the capacity to appreciate the need to take
chronic medication in the service of life preservation.
Patients on HAART will be expected to take their medication
independently. However, the patient with BPD may have an
increased need for a caregiver given the fact that they have a
physical illness. This potential need coupled with the responsibility
of taking their medication may predispose the patient to further
suicidal ideation if such a care giver is absent or restricted in what
they can offer to the patient. Additionally, if potential rejection is
perceived, they may not take their HAART as a means to indicate
their apparent need for an attachment figure to take care of them,
thus securing the return of the attachment figure.
3.6. Criterion 6
The sixth criterion is evidence of affective instability due to
marked reactivity of mood. For example, intense episodic dysphoria,
irritability, or anxiety usually lasting a few hours and only rarely
more than a few days. While the predominant mood of patients with
BPD is dvsphorlc, it is regularly interrupted by intervals of anger,
panic or hopelessness. Moreover, these intervals are not usually
relieved by feelings of well-being or satisfaction. This characteristic
might be due to the acute sensitivity of patients with BPD to
interpersonal stressors.
The poor regulation of affect may significantly influence
adherence to HAART in that their behaviour may be mood-
dependent. A patient who is feeling acutely dysphoric may not want
to take their medication based on their mood, and thus the patient
does not take it. In other words, their motivation to take the
medication may fluctuate as a function of the way they feel. Due to
the intense discomfort they are feeling, their ability to execute
rational behaviour may be compromised. Additionally, the
deleterious Side-effects of HAART could exacerbate the patient's
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uncomfortable affect. Thus non-adherence could function as an
avoidance mechanism of compounding the dysphoria.
The patient may also have learnt, through a complex combination
of classical and operant conditioning that the medication results in
their affect being worsened. Given that the patient with BPD is
susceptible to affective dysregulation, the chances that they will be
dysphoric during and following the ingestion of HAART are high. The
patient may thus misattribute the dysphoria directly to the HAART
and associates the medication with the negative affect.
Consequently, the patient avoids taking the medication as a means
of reducing discomfort.
3.7. Criterion 7
The seventh criterion is evidence of chronic feelings of emptiness.
Patients with BPD may become bored easily and consequently seek
something to do.
Similarly, they may also get bored with their HAART medication
and thus not take it as prescribed, or seek other treatment options
that are not a component of the HAART regimen, which seem more
novel. Given their feelings of emptiness they may question the
purpose of the medication, which in turn could result in
nonadherence. The patient may also mistakenly believe that the
HAART may attenuate the feelings of emptiness and boredom.
When the patient realizes that this is not the case and the feelings
are not going away, they may terminate treatment.
3.8. Criterion 8
The eighth criterion is evidence of inappropriate, intense anger or
difficulty controlling anger. For example, frequent displays of
temper, and constant, recurrent physical fights that are often
elicited within the context of relationships. Patients may become
extremely sarcastic or bitter, and displ.ay verbal outbursts. This
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behaviour is often precipitated by the perception of an attachment
figure being neglectful or abandoning.
The intense anger that patients with BPD experience toward
attachment figures is likely to extend to their medical practitioners
too. When experiencing this anger the patient may not take their
medication as prescribed, but rather dismiss or ignore the advice or
medical protocols prescribed for them. This is likely to happen
frequently given the restricted access the patient will have with
their physician. This dynamic is likely to dovetail closely with
feelings of devaluing toward attachment figures.
3.9 Criterion 9
The ninth criterion is evidence of transient, stress-related
paranoid ideation or severe dissociative symptoms as well as other
symptoms including hallucinations and ideas of reference.
Whilst these symptoms are not usually severe enough to warrant
a separate diagnosis, they are also likely to influence adherence.
Given the complex and demanding nature of HAART regimens
(Remien & Rabkin, 2002), a patient who experiences episodes of
depersonalization and other dissociative symptoms may experience
a significant amount of difficulty in adherence. It will likely have an
impact on their self-image, and their sense of stability may be
disrupted. A poor sense of stability will likely impact on adherence
in that their ability to develop and sustain systematic behavioural
patterns needed for HAARTadherence will be lowered. Additionally,
they may be preoccupied by these dissociative symptoms and either
forget to take their medication at the correct time or not realize the
importance of taking the medication given compromised reality-
testing abilities when dissociating.
On the other hand, a patient with BPD may incorporate their
HAART into their delusional/paranoid system and consequently
decreases the likelihood of adherence. A vicious cycle may develop
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whereby the patient sets up self-fulfilling prophecies. In other
words, the patient may, for example, believe that the HAART is
compounding the progression of the HIV and thus stops taking the
medication. The result is that the HIV is likely to become resistant
to the HAART, and the patients health declines, confirming their
delusion.
The criteria for making a diagnosis of BPD have been considered
separately, but it must be borne in mind that the patient diagnosed
with BPD must have five of the criteria. Consequently the individual
criteria do not function in isolation from each other in a vacuum, but
rather occur simultaneously within the same patient. As such,
delineating the impact or attempting to formulate the specific
means in which adherence is a function of the respective criterion is
limited. It is highly likely that the individual criteria interact with
one another creating a gestalt-like effect, thus exponentially
compounding the dysfunctional effects of each criterion on the
patient's life and their adherence to HAART. Teasing out the specific
role of each criterion is thus likely to be more accurate when dealing
with each clinical presentation individually. However, it does seem
likely that the properties of BPD have the potential to have
devastating influences on the patient's ability to adhere optimally to
their HAART.
Conclusion
It is well documented that patient adherence to medical advice
and prescription medication is suboptimal. While the reasons
accounting for noncompliance are varied and complex, it is essential
that they be expounded to facilitate the efficacy of medical
interventions. In no other illness is this more pertinent than with
HIV. HAART has become the first line of treatment for HIV, but
stringent adherence is a prerequisite for therapeutic efficacy. As
with other treatments, adherence to HAART is problematic. One
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factor that may play a significant role is if the patient has a
comorbid psychiatric illness. Specifically, this thesis has aimed to
illustrate how a patient with BPD might suffer innumerable
exigencies with adherence as a function of the individual properties
of their illness, which is likely to be compounded when the
properties interact with one another.
Recommendations
Given the paucity of research into the role of personality
pathology on adherence to HAART, attention must be focused onto
this area. The specific means in which Axis II disorders may
influence, both directly and indirectly an individual's ability to
comply with medical advice needs to be expounded further. This
understanding will allow medical interventions to be designed and
implemented with a patient's psychological milieu in mind.
Specifically, the need for interventions to be designed for HIV+
patients with BPD are two-fold: not only do these patients pose a
significant risk for on-going transmission given their tendency
towards sexual promiscuity and unsafe sex practices, but poor
adherence means that they can transmit treatment-resistant strains
of the virus. Thus, effective interventions will have significance for
both individual but also social health.
Limitations of the study
There are a number of limitations of this theoretical study. Firstly,
the criteria for making a diagnosis of BPD and their influence on
adherence were considered individually. As stated previously, it is
highly likely that these criteria interact creating a synergistic effect
on the patients ability to adhere. This does lend weight though to
the argument that a patient with BPD is compromised in their ability
to adhere to HAART.
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Secondly, reliable and valid epidemiological figures regarding the
prevalence of BPD in South Africa are not readily available, and thus
the relevance of the study cannot be supported by these figures.
Thirdly, only BPD was considered and not other Cluster B disorders,
which may confound the implications given that many of the cluster
B disorders have common features. Consequently, conclusions
drawn by this paper may well be extended to other Cluster B
disorders too.
Fourthly, the role of HIV on BPD has not been discussed. It has
been assumed that a linear relationship exists between BPD and
adherence, but other relationships and variables have not been
explored. For example, a circular relationship may develop whereby
BPD affects adherence, and the HIV constitutionally exacerbates the
BPD which in turn further exacerbates nonadherence.
Significance of the study
This study highlights the need for research to be conducted into
the interplay of Axis II and Axis III disorders, with specific reference
to adherence to HAART. Given that South Africa has the largest HIV
infected population in the world implies that all variables influencing
the progression and treatment of the epidemic need to be
addressed. Specifically, this paper underscores the importance of
taking into account the psychological context of the patient with HIV
and that effective treatment of the illness is not limited to the
somatic, but must consider a broader understanding, with specific
reference to personality and its associated pathology.
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